Clinical study of low concentration atropine in controlling children myopia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPD-16008844

Enrollment

Unknown

Registered

2016-07-14

Start date

2016-07-20

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

one:0.005%concentration atropine

two:0.01%concentration atropine

three:0.02% concentration atropine

four:Spectacles

five:0.02% concentration atropine, once every 2 days

Eligibility

Sex/Gender

All

Age

6 Years to 14 Years

Inclusion criteria

Inclusion criteria: Aged 6-14 years; myopia spherical equivalent degree: -1.25D to - 6.0D(-0.75D to -2.0D for 0.005% atropine group), astigmatism is less than 2.0D. The distance corrected visual acuity is greater than or equal to 0.8.

Exclusion criteria

Exclusion criteria: Congenital myopia and pathological myopia, premature and low birth weight myopia patients,with no other related myopia drugs and training method in the past six months; with significantly skew and other eye diseases; with ocular inflammatory; with history of ocular trauma, with history of ocular surgery, systemic or ocular implement qualitative sex pathological change.

Design outcomes

Primary

Measure	Time frame
myopia degree;	—

Countries

China

Contacts

Public ContactFu Aicun

The First Affiliated Hospital of Zhengzhou University

109848196@qq.com+86 15093272336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026